The Ecuador antibiotics market is majorly dependent on imports from India. Ecuador had imported antibiotics worth US $3.5 million in 2022. The launch of ... Nov 03
Dr Gopal Pemmaraju gives insights on the causes, risk factors, types, symptoms and treatment for head and neck cancer. Learn more about the warning signals ... Dec 17
Ovarian cancer is one of the most common cancers seen in women. Dr. Mukesh Bang gives valuable insights into ovarian cancer. He emphasizes the early ... Nov 26
More than 14 million new cases of cancer are diagnosed globally each year. It is estimated that there will be about 8 lakhs new cancers ... Nov 02
More than 14 million new cases of cancer are diagnosed globally each year. It is estimated that there will be about 8 lakhs new cancer ... Sep 30
It May be worth exploring hormone therapy to reduce infection severity, say, researchers ... Feb 21
Latest Corporate news updates; Pharma Feb 3rd 2022... Feb 03
Tumour shrinkage is greater in exercisers, small comparative trial results reveal ... Feb 03
Latest Corporate News; Pharma Jan1st/2022... Feb 01
Dr. Praful Barvalia informs that synchronization of homeopathy with allopathy can help prolong the asymptomatic phase in AIDS patients. He also advises about the need ... Dec 22
In a two-stage approach, the study will initially investigate the efficacy of a vaccine formulation targeting the original virus strain (D.614), while a ... Jul 09
Recommendation based on positive results from the Phase 3 CheckMate -577 trial in which Opdivo doubled disease-free survival compared to placebo in the all-... Jun 25
Tecentriq is now the first and only single-agent cancer immunotherapy with three dosing options... May 08
Sorrento intends to combine a variety of its proprietary mAbs in conjunction with the ADNAB technology platform... Apr 28
The immune system is our defensive mechanism of the body that helps in fighting infection. Protecting your immune system with the administration of ImmunoFormulation (IF) ... Mar 23
New option extends dosing from two to four weeks, reducing medical visits and improving patient convenience ... Jan 15
... Jan 05
Serum Institute Of India And Dynavax, today jointly announced that the first participants have been dosed in the Phase 1 part of the Phase 1/... Dec 24
Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80%... Dec 21
Today, the U.S. Food and Drug Administration approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose ... Dec 19
PrEP Biopharm Limited, intends to move forward with areal-world, field trial intended to validate the efficacy of its PrEP-001 against all circulating respiratory ... Dec 17
Greenwich LifeSciences collaborates with Westport Bio to in-license a pre-clinical coronavirus vaccine program that is currently at the stage of pre-clinical animal ... Dec 16
Dynavax Technologies Corporation, today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on ... Dec 11
The European Commission has granted marketing authorization for Supemtek®, a quadrivalent (four-strain) recombinant influenza vaccine, for the prevention of influenza in adults aged 18 ... Nov 20
The results of this clinical trial are expected to be available by February 2021 ... Nov 16
-Advertisements-
Saturday, June 01, 2024
_cancer.jpg)
.jpg)
